Natures Sunshine Products, Inc.
Location
Utah
Founded
1972-02-13
Website
Risk Signals
413 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Natures Sunshine Products, Inc.
Live alerts from global media, monitored by Business Radar
2025-06-27 (stockstory.org)
5 Revealing Analyst Questions From Nature's Sunshine's Q1 Earnings Call
Nature's Sunshine's first quarter was marked by strong international performance and effective risk management amid a complex trading environment. The company's results exceeded Wall Street's expectations, with CEO Terrence Moorehead attributing the outperformance to robust demand in Asia Pacific and Europe. Moorehead highlighted, "Our strategy to refocus the business on high-velocity products that offer an attractive repay purchase opportunity continued to drive strong order growth, while the expansion of our Subscribe & Thrive autoship program helped improve customer activation and drive orders." The company also increased inventory levels to hedge against evolving tariffs and supply disruptions, supporting continued product availability.
Read more
2025-06-26 (investing.com)
Nature's Sunshine announces secondary offering of 2.8 million shares By Investing.com
Nature's Sunshine announces secondary offering of 2.8 million shares
Read more
2025-06-25 (stocktitan.net)
Nature's Sunshine Secondary Stock Offering: Fosun Selling 2.85M Shares While Company Plans $15M Buyback
Natural supplements maker announces major stock offering with Fosun Pharma exit. Company signals potential $15M share buyback from offering proceeds. Get full details.
Read more
2025-06-14 (businessforhome.org)
Nature's Sunshine Renews Scholarship Fund with Eccles School of Business - Direct Selling Facts, Figures and News
Nature's Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, recently announced the renewal of its scholarship in partnership with the David Eccles School of Business at the University of Utah to support economically disadvantaged students in their education. The company has pledged $200,000 over […]
Read more
2025-06-09 (theglobeandmail.com)
Nature's Sunshine Renews Scholarship Fund with Eccles School of Business -
LEHI, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the renewal of its scholarship in partnership with the David Eccles School of Business at the University of Utah to support economically disadvantaged students in their education.
Read more
2025-06-02 (stockstory.org)
Why Nature's Sunshine (NATR) Shares Are Falling Today
Shares of wellness products company Nature's Sunshine (NASDAQ:NATR) fell 7.2% in the morning session after CEO Terrence Moorehead, announced his decision to step down from his role. The board also announced the search for his successor, and Moorehead will remain in his role until a new CEO is appointed. This interim period introduces leadership uncertainty, something the market generally dislikes.
Read more
2025-06-02 (investing.com)
Nature's Sunshine executive director will leave the position, the company seeks successor by .com
Nature's Sunshine executive director will leave the position, the company is looking for successor
Read more
2025-05-26 (ricentral.com)
3 Inflated Stocks in Hot Water | User |
The stocks featured in this article are seeing some big returns. Over the past month, they've outpaced the market due to new product launches, positive news, or even a dedicated social media following.
Read more
2025-05-19 (stockstory.org)
NATR Q1 Earnings Call: Outperformance Driven by Asia-Pacific and Europe Amid Tariff Uncertainty
Wellness products company Nature's Sunshine (NASDAQ:NATR) announced better-than-expected revenue in Q1 CY2025, with sales up 2% year on year to $113.2 million. The company expects the full year's revenue to be around $457.5 million, close to analysts' estimates. Its non-GAAP profit of $0.25 per share was 51.5% above analysts' consensus estimates.
Read more
2025-05-14 (businessforhome.org)
Nature's Sunshine Reports Strong Q1 2025 Results - Direct Selling Facts, Figures and News
Nature's Sunshine Q1 2025 revenue rose 2% to $113.2M. Strong growth in Asia and Europe.
Read more
2025-05-12 (chroniclejournal.com)
1 of Wall Street's Favorite Stock to Keep an Eye On and 2 to Be Wary Of | User | .com
1 of Wall Street's Favorite Stock to Keep an Eye On and 2 to Be Wary Of
Read more
2025-05-12 (thepilotnews.com)
1 of Wall Street's Favorite Stock to Keep an Eye On and 2 to Be Wary Of | User | thepilotnews.com
1 of Wall Street's Favorite Stock to Keep an Eye On and 2 to Be Wary Of
Read more